8i Acquisition 2 Corp.
LAXXU
NASDAQ Global Market6.00
USD
-0.20
- -
CIK
0001847846
Return %
Stock
S&P500
1Y
-40.06
18.21
3Y
-40.71
63.29
5Y
-40.71
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- c/o 6 Eu Tong Sen Street Singapore Singapore 059817
- IPO Date
- Nov 22, 2021
- CIK
- 0001847846
- Website
- 8icorp.com
- Similar Companies
- Business
- 8i Acquisition 2 Corp. (NASDAQ:LAXXU) operates as a blank check company, or special purpose acquisition company (SPAC), formed to effect mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or similar business combinations with one or more businesses, with a focus on Asia. Incorporated in January 2021 as a British Virgin Islands entity and headquartered in Singapore, the company raised $86.3 million in its November 2021 Nasdaq initial public offering through units comprising ordinary shares, warrants, and rights, targeting high-growth opportunities in sectors like artificial intelligence, internet of things, mobile internet, travel, hospitality, healthy living, aged healthcare, aesthetics, and specialized real estate.[fetch:https://www.8icorp.com] In November 2022, it completed a business combination with EUDA Health Limited, a Singapore-based digital health platform providing AI-driven personalized healthcare services including patient triage, clinician connections, wellness, urgent care, pre-existing condition management, and aftercare across Southeast Asia; the deal was amended in June 2022 to reduce the pro forma enterprise value to $172 million with earn-outs up to 4 million shares by December 2024, and the combined entity trades as EUDA Health Holdings Limited (NASDAQ: EUDA) while retaining LAXXU units amid ongoing Nasdaq compliance issues including minimum market value deficiencies as of 2025.
U.S. IPO Weekly Recap: The Shortened Holiday Week Brings Just 1 IPO